“…These episodes were reported in 7 out of 10 patients and required acute or/and preventive treatment with an alpha agonist (phenylephrine), IV fluids, beta blockers (esmolol, metoprolol), catecholamine blockers (labetalol) in 70 out of 144 sessions (49%). 27 No deaths occurred in this sample of 10 patients with a total of 144 sessions. 27 …”
Section: Review Of the Literature For Cardiac And Age Related Issues mentioning
confidence: 68%
“…The median age of the group was 79.5 years and oldest patient was a 93 year old female. 27 The sample experienced side effects that were transient in nature only and responded adequately to prompt treatment. Episodes of post stimulation hypotension (n=2) as well as episodes of tachycardia (>100 beats/min) and hypertension (>180 mm Hg) were reported.…”
Section: Review Of the Literature For Cardiac And Age Related Issues mentioning
confidence: 99%
“…27 published a retrospective review of 10 patients with severe aortic stenosis (i.e., aortic valve area ≤1.0 cm 2 ) who safely underwent ECT. The median age of the group was 79.5 years and oldest patient was a 93 year old female.…”
Section: Review Of the Literature For Cardiac And Age Related Issues mentioning
Although there is no specific age cut-off for ECT and no absolute contraindication to its use, very old age as well as the presence of cardiac conditions such as aortic stenosis are factors that may negatively impact the clinician's decision to administer ECT in the individual case.
We report our follow-up of a 100 year old female with severe aortic stenosis who has now received ECT safely for a period of 5 years. No cardiac complications have emerged during this period. Her prior unipolar depressive episode with catatonic features remains in remission with a single prophylactic ECT session every 3 months.
We have observed from our experience with this unique case that periodic multidisciplinary re-evaluation of the evolving risk-benefit profile of ECT is essential along with the inclusion of family members in this dialogue. Our patient course illustrates that neither advanced age nor severe aortic stenosis are absolute contraindications to ECT even over an extended period of time. Each case needs to be evaluated on its merits.
To our knowledge, this case represents the oldest patient in the literature where ECT has been administered safely for such an extended period in the setting of severe aortic stenosis.
“…These episodes were reported in 7 out of 10 patients and required acute or/and preventive treatment with an alpha agonist (phenylephrine), IV fluids, beta blockers (esmolol, metoprolol), catecholamine blockers (labetalol) in 70 out of 144 sessions (49%). 27 No deaths occurred in this sample of 10 patients with a total of 144 sessions. 27 …”
Section: Review Of the Literature For Cardiac And Age Related Issues mentioning
confidence: 68%
“…The median age of the group was 79.5 years and oldest patient was a 93 year old female. 27 The sample experienced side effects that were transient in nature only and responded adequately to prompt treatment. Episodes of post stimulation hypotension (n=2) as well as episodes of tachycardia (>100 beats/min) and hypertension (>180 mm Hg) were reported.…”
Section: Review Of the Literature For Cardiac And Age Related Issues mentioning
confidence: 99%
“…27 published a retrospective review of 10 patients with severe aortic stenosis (i.e., aortic valve area ≤1.0 cm 2 ) who safely underwent ECT. The median age of the group was 79.5 years and oldest patient was a 93 year old female.…”
Section: Review Of the Literature For Cardiac And Age Related Issues mentioning
Although there is no specific age cut-off for ECT and no absolute contraindication to its use, very old age as well as the presence of cardiac conditions such as aortic stenosis are factors that may negatively impact the clinician's decision to administer ECT in the individual case.
We report our follow-up of a 100 year old female with severe aortic stenosis who has now received ECT safely for a period of 5 years. No cardiac complications have emerged during this period. Her prior unipolar depressive episode with catatonic features remains in remission with a single prophylactic ECT session every 3 months.
We have observed from our experience with this unique case that periodic multidisciplinary re-evaluation of the evolving risk-benefit profile of ECT is essential along with the inclusion of family members in this dialogue. Our patient course illustrates that neither advanced age nor severe aortic stenosis are absolute contraindications to ECT even over an extended period of time. Each case needs to be evaluated on its merits.
To our knowledge, this case represents the oldest patient in the literature where ECT has been administered safely for such an extended period in the setting of severe aortic stenosis.
“…Clinical data included details about medications, results of imaging studies, data related to ECT sessions, and evidence of complications related to cardiovascular disease during the periprocedural period, which was defined as the time beginning with the administration of intravenous glycopyrrolate and the induction of anesthesia and ending 24 hours after dismissal from the postanesthesia care unit. 12 Descriptive statistics were used. The Mayo Clinic Institutional Review Board granted permission to undertake this retrospective study.…”
Electroconvulsive therapy was safe for 8 patients with unrepaired AAA treated at our institution. Our findings may be informative to clinicians who manage the care of patients with unrepaired AAA who are undergoing ECT.
“…12 Concomitant use of antihypertensives and antiarrhythmics may have raised the seizure threshold in our patient who was given metoprolol before the first ECT because of aortic stenosis to prevent severe tachycardia and hypertension. 16,28 In conclusion, patients with an exceptionally high seizure threshold at their first ECT are rare. Until now, besides our patient, very few have been reported in the literature.…”
Because reports on exceptionally high initial seizure thresholds in ECT are rare, no definite conclusions can be drawn regarding its possible risk factors and management. However, since high initial seizure thresholds can complicate ECT, it is clinically important to further investigate this phenomenon.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.